Index S&P 500
P/E 36.83
EPS (ttm) 4.43
Insider Own 0.20%
Shs Outstand 463.50M
Perf Week -5.11%
Market Cap 72.79B
Forward P/E 26.82
EPS next Y 6.08
Insider Trans -3.29%
Shs Float 461.18M
Perf Month -11.91%
Income 2.07B
PEG 3.32
EPS next Q 1.31
Inst Own 94.50%
Short Float / Ratio 0.80% / 1.86
Perf Quarter 0.97%
Sales 8.09B
P/S 8.99
EPS this Y 5.20%
Inst Trans 0.02%
Short Interest 3.71M
Perf Half Y 8.55%
Book/sh 9.70
P/B 16.81
EPS next Y 12.57%
ROA 14.80%
Target Price 215.08
Perf Year -4.79%
Cash/sh 4.72
P/C 34.58
EPS next 5Y 11.10%
ROE 45.70%
52W Range 124.15 - 187.82
Perf YTD 11.29%
Dividend 1.50
P/FCF 88.01
EPS past 5Y 15.50%
ROI 17.20%
52W High -13.17%
Beta 0.77
Dividend % 0.92%
Quick Ratio 1.90
Sales past 5Y 8.80%
Gross Margin 69.90%
52W Low 31.37%
ATR 4.10
Employees 13800
Current Ratio 3.30
Sales Q/Q 0.70%
Oper. Margin 32.40%
RSI (14) 36.73
Volatility 2.11% 2.28%
Optionable Yes
Debt/Eq 1.46
EPS Q/Q -5.30%
Profit Margin 25.60%
Rel Volume 0.68
Prev Close 164.30
Shortable Yes
LT Debt/Eq 1.46
Earnings May 04 BMO
Payout 30.40%
Avg Volume 1.99M
Price 163.09
Recom 1.70
SMA20 -5.58%
SMA50 -6.07%
SMA200 1.73%
Volume 1,346,568
Change -0.74%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-12-22 Initiated
Piper Sandler
Overweight
$205
Nov-18-21 Initiated
Morgan Stanley
Overweight
$40
Nov-18-21 Initiated
Morgan Stanley
Overweight
$264
Aug-05-21 Resumed
Credit Suisse
Outperform
$206
Jul-16-21 Downgrade
Raymond James
Outperform → Mkt Perform
Mar-08-21 Upgrade
Raymond James
Mkt Perform → Outperform
$166
Mar-08-21 Upgrade
BofA Securities
Neutral → Buy
$180
Sep-21-20 Initiated
Atlantic Equities
Overweight
$191
Aug-14-20 Upgrade
Edward Jones
Hold → Buy
Aug-12-20 Downgrade
Gabelli & Co
Buy → Hold
May-27-20 Initiated
Jefferies
Buy
$152
Jan-10-20 Initiated
Raymond James
Mkt Perform
Sep-09-19 Initiated
Goldman
Buy
$145
Jul-01-19 Downgrade
BofA/Merrill
Buy → Neutral
$111 → $120
Jun-11-19 Initiated
Barclays
Overweight
$120
May-23-19 Initiated
Guggenheim
Buy
$114
May-03-19 Downgrade
Gabelli & Co
Buy → Hold
$108
Mar-20-19 Initiated
SunTrust
Hold
Mar-04-19 Upgrade
Stifel
Hold → Buy
$97 → $110
Jan-23-19 Initiated
UBS
Neutral
$86
Show Previous Ratings
Jun-09-23 06:15PM
09:00AM
Jun-04-23 10:00AM
May-30-23 04:30PM
May-25-23 07:30AM
05:19AM
Loading…
May-18-23 05:19AM
May-15-23 09:24AM
May-12-23 02:10PM
May-11-23 04:05PM
08:58AM
May-09-23 10:22AM
May-05-23 03:44PM
May-04-23 11:16PM (Thomson Reuters StreetEvents)
04:06PM (Investor's Business Daily)
02:59PM
12:30PM
Loading…
12:30PM
12:04PM
11:17AM
09:30AM
09:27AM (Investor's Business Daily)
08:25AM
07:35AM
07:00AM
May-03-23 11:46AM
08:48AM
May-02-23 06:15PM
May-01-23 08:30AM
06:20AM
Apr-30-23 05:09AM
Apr-28-23 10:07AM
10:00AM
Loading…
10:00AM
Apr-27-23 06:15PM
10:02AM
Apr-24-23 02:35PM
Apr-21-23 06:15PM
Apr-18-23 11:40AM
09:27AM
Apr-17-23 04:49PM
Apr-14-23 05:11PM
10:49AM (The Wall Street Journal)
10:00AM (The Wall Street Journal)
Apr-10-23 06:00PM (Investor's Business Daily)
Apr-08-23 09:48AM
Apr-05-23 08:00AM
Apr-03-23 07:24AM
07:09AM
Mar-31-23 10:37AM
Mar-30-23 08:30AM
Mar-29-23 09:36AM
01:00AM
Mar-27-23 04:00PM (Investor's Business Daily)
Mar-17-23 06:15PM
08:20AM
Mar-16-23 04:26PM
11:30AM
Mar-13-23 08:00AM
Mar-03-23 08:30AM
Mar-01-23 11:40AM
07:00AM
06:30AM
Feb-28-23 08:30AM
Feb-27-23 07:56AM
Feb-17-23 05:24PM
02:02PM (Investor's Business Daily)
11:32AM
Feb-15-23 03:43PM
Feb-14-23 04:08PM (Investor's Business Daily) +5.37%
03:34PM
02:30PM
11:57AM
11:17AM
11:12AM
10:48AM
09:11AM (Investor's Business Daily)
08:32AM
08:22AM
08:15AM
07:00AM
Feb-13-23 11:40AM
08:15AM
Feb-11-23 09:00AM
Feb-10-23 08:37AM
Feb-09-23 06:15PM
Feb-08-23 04:10PM
Feb-07-23 10:00AM
Feb-02-23 06:15PM
Jan-28-23 10:15AM
Jan-27-23 06:15PM
11:40AM
Jan-19-23 12:55PM (The Wall Street Journal)
Jan-18-23 10:15AM
Jan-17-23 09:37AM
Jan-12-23 06:59PM
01:25PM
01:10PM
Jan-11-23 04:52PM
11:40AM
09:45AM
Jan-05-23 08:37AM
Jan-03-23 02:26PM
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. The company also offers parasiticides; vaccines; anti-infectives; other pharmaceutical products; dermatology; and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products and laboratory; and other non-pharmaceutical products. It markets its products to veterinarians, livestock producers, and pet owners. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
PECK KRISTIN C Chief Executive Officer May 23 Option Exercise 41.83 13,000 543,790 69,843 May 25 04:13 PM PECK KRISTIN C Chief Executive Officer May 23 Sale 176.56 13,000 2,295,335 56,843 May 25 04:13 PM Lagano Roxanne Executive Vice President Apr 18 Option Exercise 79.85 4,338 346,398 30,695 Apr 19 04:18 PM Lagano Roxanne Executive Vice President Apr 18 Sale 175.94 4,338 763,228 26,357 Apr 19 04:18 PM Lagano Roxanne Executive Vice President Feb 14 Option Exercise 79.85 13,010 1,038,843 39,367 Feb 16 04:18 PM Lagano Roxanne Executive Vice President Feb 14 Sale 175.00 13,010 2,276,750 26,357 Feb 16 04:18 PM Lagano Roxanne Executive Vice President Jul 22 Option Exercise 79.85 2,167 173,038 25,854 Jul 26 04:36 PM Lagano Roxanne Executive Vice President Jul 22 Sale 180.26 2,167 390,623 23,687 Jul 26 04:36 PM PECK KRISTIN C Chief Executive Officer Jul 21 Option Exercise 36.49 9,689 353,599 49,432 Jul 25 04:08 PM PECK KRISTIN C Chief Executive Officer Jul 21 Sale 180.00 9,689 1,744,020 39,743 Jul 25 04:08 PM PECK KRISTIN C Chief Executive Officer Jul 07 Option Exercise 30.89 311 9,607 40,054 Jul 11 04:08 PM PECK KRISTIN C Chief Executive Officer Jul 07 Sale 180.00 311 55,980 39,743 Jul 11 04:08 PM Lagano Roxanne Executive Vice President Jun 27 Option Exercise 79.85 4,334 346,076 28,021 Jun 28 05:29 PM Lagano Roxanne Executive Vice President Jun 27 Sale 175.00 4,334 758,450 23,687 Jun 28 05:29 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite